Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 20/20 | 0.51 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.51 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.51 |
| ▸ | GSPT1 | P15170 | 7/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30767695 | 1.00 | CRBN (0.51) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL27351610 | 1.00 | CRBN (0.51) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL26740495 | 1.00 | CRBN (0.51) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL31438897 | 1.00 | CRBN (0.51) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL26740499 | 0.94 | CRBN (0.49) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL26740658 | 0.93 | CRBN (0.49) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL26740461 | 0.92 | CRBN (0.53) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL26740467 | 0.92 | CRBN (0.53) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL29739376 | 0.90 | CRBN (0.49) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 | |
| SCHEMBL29739487 | 0.90 | CRBN (0.49) | CRBNCSNK1A1IKZF2GSPT1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024015565-A1 | METHODS OF PREPARING AN ISOINDOLINONE DERIVATIVE AND CRYSTAL FORMS THEREOF | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | WO | disclosed |